AWM
IART icon

Activest Wealth Management’s Integra LifeSciences IART Stock Holding History

Activest Wealth Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14
Closed -$203 – 1110
2025
Q1 		$308 Buy
14
+13
+1,300% +$306 ﹤0.01% 906
2024
Q4 		$23 Buy
+1
New +$22 ﹤0.01% 833

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Activest Wealth Management's IART Position: Q2 2025 in Review

Activest Wealth Management sold out of Integra LifeSciences (IART) in Q2 2025, closing a stake of 14 shares — an estimated $203 sold.

Activest Wealth Management first reported a position in IART in Q4 2024 and held it in 2 quarters. The position peaked at $308 in Q1 2025. 208 funds tracked by Wall St. Rank hold IART as of Q2 2025.

  • Activest Wealth Management reported no remaining Integra LifeSciences position as of Q2 2025 after selling out during the quarter.
  • Activest Wealth Management sold 14 Integra LifeSciences shares in Q2 2025, an estimated $203.
  • Activest Wealth Management first reported a position in Integra LifeSciences in Q4 2024 and held it in 2 quarters.
  • Activest Wealth Management's Integra LifeSciences position peaked at $308 in Q1 2025.
  • 208 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2025.

Based on Activest Wealth Management's 13F filing for Q2 2025, filed 29 Jul 2025.